Hendrik Isbarn

Universität Hamburg, Regio Kliniken, Vivantes Klinikum

Papers

5

Total Citations

159

H-Index

3

About

Hendrik Isbarn is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes in prostate cancer care, particularly through comparative studies of open retropubic radical prostatectomy (ORP) and robot-assisted laparoscopic radical prostatectomy (RARP). His landmark study, cited over 110 times, compared these techniques in nearly 11,000 men treated by highly trained surgeons, providing critical evidence on oncological, functional, and surgical outcomes. Isbarn has also challenged clinical paradigms, demonstrating the safety of continuing low-dose aspirin during radical prostatectomy—a finding that has influenced perioperative management and earned over 30 citations. His investigations extend to guideline adherence for pelvic lymph node dissection and the prevention of symptomatic lymphoceles, with a recent prospective randomized trial examining the role of peritoneal bladder flaps in robotic surgery. Through these contributions, Isbarn has shaped best practices in urologic oncology, offering data-driven insights that directly impact patient care. His work reflects a commitment to rigorous, comparative research that bridges surgical innovation and evidence-based medicine.

Research Focus

Key Achievements

3
H-Index
5
Papers
159
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
A comparative study of robot‐assisted and open radical prostatectomy in 10 790 men treated by highly trained surgeons for both procedures
113 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: Universität Hamburg, Regio Kliniken, Vivantes Klinikum

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago